Table 2.
Clinical Outcomes
Variable | Control (n=28) | Warming (n=28) | Difference (95% CI) |
---|---|---|---|
28-day mortality, n (%) | 12 (43) | 5 (18) | −25 ([−48]- [−2]) |
Delta-SOFA, mean (SD) | −1.6 (3.0) | −1.8 (2.4) | −0.2 ([−1.6] – 1.3) |
28-day hospital-free days, median (IQR) | 0 (0–11.3) | 13.1 (0–16.8) | 2.6 (0–11.6) |
28-day ventilator-free days, median (IQR) | 17.6 (0–24.2) | 21.6 (2.6–24.1) | 0.1 (−6.1–1.0) |
Secondary infection within 30 days, n (%) | 9 (32) | 8 (29) | −4 ([−28] – 20) |
Abdominal | 1 (11) | 3 (38) | |
Bone/soft tissue | 1 (11) | 0 (0) | |
Catheter | 1 (11) | 1 (13) | |
Pneumonia | 4 (44) | 4 (50) | |
Urinary | 1 (11) | 0 (0) | |
Wound | 1 (11) | 0 (0) |